TURKISH JOURNAL OF GERIATRICS-TURK GERIATRI DERGISI, vol.19, no.1, pp.27-34, 2016 (SCI-Expanded)
Introduction: Elderly patients are under-represented in the clinical trials of patients with metastatic gastric cancer (GC); therefore, the efficacy and tolerability of palliative chemotherapy are unclear in these patients. We aimed to assess the efficacy and tolerability of first-line palliative chemotherapy in elderly patients (age >= 70 years) with metastatic GC.